Abiopharma

The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)

Edgewise Therapeutics - Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

CoyaTherapeutics - Coya Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Frontotemporal Dementia (FTD)

Novo Nordisks Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America

Ensysce Biosciences Issues Annual Shareholder Letter

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference

Protara Therapeutics Receives Both FDA Breakthrough Therapy and Fast Track Designations for TARA-002 in Pediatric Patients with Lymphatic Malformations

Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT™ XR in the Journal of Clinical Endocrinology and Metabolism

Stryker to announce financial results for its fourth quarter and full year 2025